{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:25:38Z","timestamp":1780727138055,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic suppurative otitis media (CSOM) is a widespread, debilitating problem with poorly understood immunology. Here, we assess the host response to middle ear infection over the course of a month post-infection in a mouse model of CSOM and in human subjects with the disease. Using multiparameter flow cytometry and a binomial generalized linear machine learning model, we identified Ly6G, a surface marker of mature neutrophils, as the most informative factor of host response driving disease in the CSOM mouse model. Consistent with this, neutrophils were the most abundant cell type in infected mice and Ly6G expression tracked with the course of infection. Moreover, neutrophil-specific immunomodulatory treatment using the neutrophil elastase inhibitor GW 311616A significantly reduces bacterial burden relative to ofloxacin-only treated animals in this model. The levels of dsDNA in middle ear effusion samples are elevated in both humans and mice with CSOM and decreased during treatment, suggesting that dsDNA may serve as a molecular biomarker of treatment response. Together these data strongly implicate neutrophils in the ineffective immune response to <jats:italic>P. aeruginosa<\/jats:italic> infection in CSOM and suggest that immunomodulatory strategies may benefit drug-tolerant infections for chronic biofilm-mediated disease.<\/jats:p>","DOI":"10.1038\/s41522-021-00200-z","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T10:02:48Z","timestamp":1617703368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Treatment with a neutrophil elastase inhibitor and ofloxacin reduces P. aeruginosa burden in a mouse model of chronic suppurative otitis media"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6241-8558","authenticated-orcid":false,"given":"K. M.","family":"Khomtchouk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6803-4619","authenticated-orcid":false,"given":"L. I.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. B.","family":"Khomtchouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4154-8908","authenticated-orcid":false,"given":"A.","family":"Kouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Koliesnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5750-7505","authenticated-orcid":false,"given":"D.","family":"Pletzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2499-9448","authenticated-orcid":false,"given":"P. L.","family":"Bollyky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. L.","family":"Santa Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"200_CR1","unstructured":"Tacconelli, E. & Magrini, N. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. 1\u20137 (World Health Organization, 2019)."},{"key":"200_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.tim.2008.12.003","volume":"17","author":"DJ Hassett","year":"2009","unstructured":"Hassett, D. J. et al. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol. 17, 130\u2013138 (2009).","journal-title":"Trends Microbiol."},{"key":"200_CR3","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","volume":"284","author":"JW Costerton","year":"1999","unstructured":"Costerton, J. W., Stewart, P. S. & Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318\u20131322 (1999).","journal-title":"Science"},{"key":"200_CR4","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2217\/fmb.10.125","volume":"5","author":"N Hoiby","year":"2010","unstructured":"Hoiby, N., Ciofu, O. & Bjarnsholt, T. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol. 5, 1663\u20131674 (2010).","journal-title":"Future Microbiol."},{"key":"200_CR5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/iai.28.2.546-556.1980","volume":"28","author":"J Lam","year":"1980","unstructured":"Lam, J., Chan, R., Lam, K. & Costerton, J. W. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 28, 546\u2013556 (1980).","journal-title":"Infect. Immun."},{"key":"200_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1574-695X.2012.00938.x","volume":"65","author":"W Zimmerli","year":"2012","unstructured":"Zimmerli, W. & Moser, C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol. Med. Microbiol. 65, 158\u2013168 (2012).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"200_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s12070-007-0038-x","volume":"59","author":"PK Maji","year":"2007","unstructured":"Maji, P. K., Chatterjee, T. K., Chatterjee, S., Chakrabarty, J. & Mukhopadhyay, B. B. The investigation of bacteriology of chronic suppurative otitis media in patients attending a tertiary care hospital with special emphasis on seasonal variation. Indian J. Otolaryngol. Head Neck Surg. 59, 128\u2013131 (2007).","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"200_CR8","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1007\/s00405-013-2766-8","volume":"271","author":"X Gu","year":"2014","unstructured":"Gu, X., Keyoumu, Y., Long, L. & Zhang, H. Detection of bacterial biofilms in different types of chronic otitis media. Eur. Arch. Otorhinolaryngol. 271, 2877\u20132883 (2014).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"200_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.amjoto.2009.09.010","volume":"32","author":"J Saunders","year":"2011","unstructured":"Saunders, J., Murray, M. & Alleman, A. Biofilms in chronic suppurative otitis media and cholesteatoma: scanning electron microscopy findings. Am. J. Otolaryngol. 32, 32\u201337 (2011).","journal-title":"Am. J. Otolaryngol."},{"key":"200_CR10","unstructured":"Acuin, J. Chronic suppurative otitis media: burden of Illness and management options. 1\u201383 (World Health Organization, 2004)."},{"key":"200_CR11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1177\/0194599811419098","volume":"145","author":"I Fishman","year":"2011","unstructured":"Fishman, I. et al. Demographics and microbiology of otorrhea through patent tubes failing ototopical and\/or oral antibiotic therapy. Otolaryngol. Head Neck Surg. 145, 1025\u20131029 (2011).","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"200_CR12","doi-asserted-by":"publisher","first-page":"1900982","DOI":"10.1183\/13993003.00982-2019","volume":"54","author":"HR Stagg","year":"2019","unstructured":"Stagg, H. R. et al. Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance. Eur. Respir. J. 54, 1900982 (2019).","journal-title":"Eur. Respir. J."},{"key":"200_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3389\/fchem.2019.00824","volume":"7","author":"A Verderosa","year":"2019","unstructured":"Verderosa, A., Totsika, M. & Fairfull-Smith, K. Bacterial biofilm eradication agents: a current review. Front. Chem. 7, 824 (2019).","journal-title":"Front. Chem."},{"key":"200_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1574-695X.2011.00858.x","volume":"65","author":"L Yang","year":"2011","unstructured":"Yang, L. et al. Combating biofilms. FEMS Immunol. Med. Microbiol. 65, 146\u2013157 (2011).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"200_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gendis.2019.04.001","volume":"6","author":"P Pachori","year":"2019","unstructured":"Pachori, P., Gothalwal, R. & Gandhi, P. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review. Genes Dis. 6, 109\u2013119 (2019).","journal-title":"Genes Dis."},{"key":"200_CR16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1159\/000319909","volume":"2","author":"ET Berends","year":"2010","unstructured":"Berends, E. T. et al. Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps. J. Innate Immun. 2, 576\u2013586 (2010).","journal-title":"J. Innate Immun."},{"key":"200_CR17","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1128\/IAI.73.6.3693-3701.2005","volume":"73","author":"TS Walker","year":"2005","unstructured":"Walker, T. S. et al. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect. Immun. 73, 3693\u20133701 (2005).","journal-title":"Infect. Immun."},{"key":"200_CR18","doi-asserted-by":"publisher","first-page":"ftaa018","DOI":"10.1093\/femspd\/ftaa018","volume":"78","author":"M Alhede","year":"2020","unstructured":"Alhede, M. et al. The origin of extracellular DNA in bacterial biofilm infections in vivo. Path. Dis. 78, ftaa018 (2020).","journal-title":"Path. Dis."},{"key":"200_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053837","volume":"8","author":"RB Thornton","year":"2013","unstructured":"Thornton, R. B. et al. Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media \u2014a potential treatment target. PLoS ONE 8, e53837 (2013).","journal-title":"PLoS ONE"},{"key":"200_CR20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jinf.2005.07.017","volume":"52","author":"A Koomer","year":"2006","unstructured":"Koomer, A., Quinn, T., Bamberger, D. & Herndon, B. L. Neutrophil antimicrobial interaction in the established infection: effect on Staphylococcus aureus. J. Infect. 52, 320\u2013328 (2006).","journal-title":"J. Infect."},{"key":"200_CR21","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.1128\/AAC.03514-14","volume":"58","author":"SM Caceres","year":"2014","unstructured":"Caceres, S. M. et al. Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products. Antimicrob. Agents Chemother. 58, 6851\u20136860 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"200_CR22","doi-asserted-by":"publisher","first-page":"26102","DOI":"10.3402\/jom.v6.26102","volume":"6","author":"J Hirschfeld","year":"2014","unstructured":"Hirschfeld, J. Dynamic interactions of neutrophils and biofilms. J. Oral Microbiol. 6, 26102 (2014).","journal-title":"J. Oral Microbiol."},{"key":"200_CR23","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.1128\/IAI.00922-06","volume":"74","author":"A Sonawane","year":"2006","unstructured":"Sonawane, A., Jyot, J., During, R. & Ramphal, R. Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa. Infect. Immun. 74, 6682\u20136689 (2006).","journal-title":"Infect. Immun."},{"key":"200_CR24","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3389\/fimmu.2018.00732","volume":"9","author":"H Domon","year":"2018","unstructured":"Domon, H. et al. Neutrophil elastase subverts the immune response by cleaving toll-like receptors and cytokines in pneumococcal pneumonia. Front. Immunol. 9, 732 (2018).","journal-title":"Front. Immunol."},{"key":"200_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fpubh.2013.00019","volume":"1","author":"G Pott","year":"2013","unstructured":"Pott, G., Beard, K., Bryan, C., Merrick, D. & Shapiro, L. Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cells. Front. Public Health 1, 19 (2013).","journal-title":"Front. Public Health"},{"key":"200_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/ppul.20167","volume":"39","author":"D Woods","year":"2005","unstructured":"Woods, D., Cantin, A., Cooley, J., Kenney, D. & Remold-O\u2019Donnell, E. Aerosol treatment with MNEI suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Pediatr. Pulmonol. 39, 141\u2013149 (2005).","journal-title":"Pediatr. Pulmonol."},{"key":"200_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008187","volume":"7","author":"G Wen","year":"2018","unstructured":"Wen, G. et al. Genetic and pharmacologic inhibition of the neutrophil elastase inhibits experimental atherosclerosis. J. Am. Heart Assoc. 7, e008187 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"200_CR28","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.ijporl.2009.09.034","volume":"73","author":"PA Schachern","year":"2009","unstructured":"Schachern, P. A. et al. Effect of lipooligosaccharide mutations of Haemophilus influenzae on the middle and inner ears. Int J. Pediatr. Otorhinolaryngol. 73, 1757\u20131760 (2009).","journal-title":"Int J. Pediatr. Otorhinolaryngol."},{"key":"200_CR29","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1067\/mhn.2002.124935","volume":"126","author":"OB Piltcher","year":"2002","unstructured":"Piltcher, O. B. et al. A rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection: methods and disease course. Otolaryngol. Head Neck Surg. 126, 490\u2013498 (2002).","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"200_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijporl.2010.09.024","volume":"75","author":"G Aynali","year":"2011","unstructured":"Aynali, G. et al. The effects of methylprednisolone, montelukast and indomethacine in experimental otitis media with effusion. Int J. Pediatr. Otorhinolaryngol. 75, 15\u201319 (2011).","journal-title":"Int J. Pediatr. Otorhinolaryngol."},{"key":"200_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1159\/000341163","volume":"17","author":"Q Huang","year":"2012","unstructured":"Huang, Q. et al. Hypoxia-inducible factor and vascular endothelial growth factor pathway for the study of hypoxia in a new model of otitis media with effusion. Audio. Neurootol. 17, 349\u2013356 (2012).","journal-title":"Audio. Neurootol."},{"key":"200_CR32","first-page":"175342592093366","volume":"24","author":"A Tuoheti","year":"2020","unstructured":"Tuoheti, A., Gu, X., Cheng, X. & Zhang, H. Silencing Nrf2 attenuates chronic suppurative otitis media by inhibiting pro-inflammatory cytokine secretion through up-regulating TLR4. Innate Immun. 24, 1753425920933661 (2020).","journal-title":"Innate Immun."},{"key":"200_CR33","doi-asserted-by":"publisher","first-page":"eabc1828","DOI":"10.1126\/sciadv.abc1828","volume":"6","author":"K Khomtchouk","year":"2020","unstructured":"Khomtchouk, K. et al. A novel mouse model of Chronic Suppurative Otitis Media and its use in preclinical antibiotic evaluation. Sci. Adv. 6, eabc1828 (2020).","journal-title":"Sci. Adv."},{"key":"200_CR34","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A 87, 636\u2013645 (2015).","journal-title":"Cytometry A"},{"key":"200_CR35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.immuni.2018.02.002","volume":"48","author":"M Evrard","year":"2018","unstructured":"Evrard, M. et al. Developmental analysis of bone marrow neutrophils reveals populations specialized in expansion, trafficking, and effector functions. Immunity 48, 364\u2013379 (2018).","journal-title":"Immunity"},{"key":"200_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","volume":"15","author":"RM Donlan","year":"2002","unstructured":"Donlan, R. M. & Costerton, J. W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167\u2013193 (2002).","journal-title":"Clin. Microbiol. Rev."},{"key":"200_CR37","first-page":"fty023","volume":"76","author":"JF Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez, J. F., Hahn, M. M. & Gunn, J. S. Chronic biofilm-based infections: skewing of the immune response. Path. Dis. 76, fty023 (2018).","journal-title":"Path. Dis."},{"key":"200_CR38","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1084\/jem.20161621","volume":"214","author":"JF Deniset","year":"2017","unstructured":"Deniset, J. F., Surewaard, B. G., Lee, W. Y. & Kubes, P. Splenic Ly6Ghigh mature and Ly6Gint immature neutrophils contribute to eradication of S. pneumoniae. J. Exp. Med. 214, 1333\u20131350 (2017).","journal-title":"J. Exp. Med."},{"key":"200_CR39","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1182\/blood-2008-09-177287","volume":"113","author":"KJ Eash","year":"2009","unstructured":"Eash, K. J., Means, J. M., White, D. W. & Link, D. C. CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions. Blood 113, 4711\u20134719 (2009).","journal-title":"Blood"},{"key":"200_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04538-3","volume":"7","author":"\u00c1 S\u00e1nchez","year":"2017","unstructured":"S\u00e1nchez, \u00c1. et al. Map3k8 controls granulocyte colony-stimulating factor production and neutrophil precursor proliferation in lipopolysaccharide-induced emergency granulopoiesis. Sci. Rep. 7, 5010 (2017).","journal-title":"Sci. Rep."},{"key":"200_CR41","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.1073\/pnas.1721949115","volume":"115","author":"M Bhattacharya","year":"2018","unstructured":"Bhattacharya, M. et al. Staphylococcus aureus biofilms release leukocidins to elicit extracellular trap formation and evade neutrophil-mediated killing. PNAS 115, 7416\u20137421 (2018).","journal-title":"PNAS"},{"key":"200_CR42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1099\/jmm.0.005728-0","volume":"58","author":"QM Parks","year":"2009","unstructured":"Parks, Q. M. et al. Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J. Med. Microbiol. 58, 492\u2013502 (2009).","journal-title":"J. Med. Microbiol."},{"key":"200_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.tim.2004.11.004","volume":"1","author":"L Hall\u2010Stoodley","year":"2005","unstructured":"Hall\u2010Stoodley, L. & Stoodley, P. Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol. 1, 7\u201310 (2005).","journal-title":"Trends Microbiol."},{"key":"200_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/archotol.125.3.337","volume":"125","author":"M Ohyama","year":"1999","unstructured":"Ohyama, M. et al. Ofloxacin otic solution in patients with otitis media: an analysis of drug concentrations. Arch. Otolaryngol. Head Neck Surg. 125, 337\u2013340 (1999).","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"200_CR45","doi-asserted-by":"publisher","first-page":"6746","DOI":"10.1128\/JB.183.23.6746-6751.2001","volume":"183","author":"AL Spoering","year":"2001","unstructured":"Spoering, A. L. & Lewis, K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183, 6746\u20136751 (2001).","journal-title":"J. Bacteriol."},{"key":"200_CR46","doi-asserted-by":"crossref","unstructured":"Pletzer, D., Mansour, S. C., Wuerth, K., Rahanjam, N., Hancock, R. E. W. New mouse model for chronic infections by Gram-negative bacteria enabling the study of anti-infective efficacy and host-microbe interactions. 8, e00140-17 (2017).","DOI":"10.1128\/mBio.00140-17"},{"key":"200_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3109\/00016489.2015.1082191","volume":"136","author":"Y Varsak","year":"2016","unstructured":"Varsak, Y. & Santa Maria, P. Mouse model of experimental Eustachian tube occlusion: a surgical technique. Acta Oto-Laryngol. 136, 12\u201317 (2016).","journal-title":"Acta Oto-Laryngol."},{"key":"200_CR48","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/cyto.a.22012","volume":"81","author":"S Rose","year":"2012","unstructured":"Rose, S., Misharin, A. & Perlman, H. A novel Ly6C\/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytometry 81, 343\u2013350 (2012).","journal-title":"Cytometry"},{"key":"200_CR49","doi-asserted-by":"publisher","first-page":"773","DOI":"10.4049\/jimmunol.1500633","volume":"195","author":"C Chester","year":"2015","unstructured":"Chester, C. & Maecker, H. T. Algorithmic tools for high-dimensional cytometry data. J. Immunol. 195, 773\u2013779 (2015).","journal-title":"J. Immunol."},{"key":"200_CR50","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/cyto.a.20901","volume":"77A","author":"E Lugli","year":"2010","unstructured":"Lugli, E., Roederer, M. & Cossarizza, A. Data analysis in flow cytometry: the future just started. Cytometry 77A, 705\u2013713 (2010).","journal-title":"Cytometry"},{"key":"200_CR51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nri.2016.56","volume":"16","author":"Y Saeys","year":"2016","unstructured":"Saeys, Y., Van Gassen, S. & Lambrecht, B. Computational flow cytometry: helping to make sense of high-dimensional immunology data. Nat. Rev. Immunol. 16, 449\u2013462 (2016).","journal-title":"Nat. Rev. Immunol."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-021-00200-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-021-00200-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-021-00200-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T20:33:06Z","timestamp":1670013186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-021-00200-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["200"],"URL":"https:\/\/doi.org\/10.1038\/s41522-021-00200-z","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.M.K., P.L.B., D.P., and P.S.M. are inventors on patent applications for novel drugs against <i>P. aeruginosa<\/i> (nos. 15\/219,073; 62\/027721; 62\/027698; 63\/024,963; and 62\/873,717). The rest of the authors declare that there are no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}